Companies Investors People

Drop to look up

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing
Alternatives

For iPhone and iPad

Resources

Documentation
Use Cases
CLI
MCP
Sitemap

aVenture is an AI-native agentic deep research tool for researching and finding companies and people, and is a high-quality alternative to AlphaSense, CB Insights, Crunchbase, Dealroom, Harmonic, Owler, Perplexity Finance, PitchBook, Preqin, PrivCo, Synaptic, and Tracxn.

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Terms of service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

XVIVO

XVIVO

XVIVO Group develops machine perfusion technologies for organ transplantation.

: 210
: Public company
: 1998
: Mölndal, Västra Götaland, SESweden

XVIVO Group AB, headquartered in the Gothenburg area of Sweden, is a medical technology company focused on organ transplantation. The company develops and supplies machine perfusion equipment and preservation solutions used to preserve, transport and assess hearts, lungs, livers and kidneys outside the body, including kidney perfusion transport systems, lung perfusion and evaluation platforms, lung preservation solutions for cold static storage, and related consumables.

It also provides organ recovery and perfusion services to transplant clinics, principally in the United States, alongside training and knowledge resources for clinical teams. XVIVO is listed on Nasdaq Stockholm under the ticker XVIVO and operates with offices and research sites in Europe and North America.

Products & Services

Kidney Assist Transport
XVIVO portable hypothermic machine perfusion device preserving donor kidneys for up to 24 hours.
Competes with

Similar Companies

Waters Medical Systems

wtrs.com

Organ Recovery Systems

organ-recovery.com

BMI OrganBank

bmiorganbank.com

Paragonix Technologies

TransMedics

transmedics.com

Bridge to Life

bridgetolife.com

eGenesis

egenesisbio.com

Vascular Perfusion Solutions

ClonOrgan Biotechnology

clonorgan.com

X-Therma

x-therma.com

IGL

igl-group.com

Miromatrix Medical

miromatrix.com

Until

untillabs.com

BiomedInnovations

Harvard Apparatus Regenerative Technology

hregen.com

Relavo

relavomedical.com

Makana Therapeutics

Velomedix

Nortis

nortisbio.com

Perfusion Medical

Quick Facts

Who are XVIVO's competitors?

Companies similar to XVIVO include Waters Medical Systems, Organ Recovery Systems, BMI OrganBank and Paragonix Technologies.

When was XVIVO founded?

XVIVO was founded in 1998.

Where is XVIVO's headquarters located?

XVIVO's headquarters is located in Mölndal, Västra Götaland, SE.

When was XVIVO's last funding round?

XVIVO's most recent funding round was for SEK440M (SEK) in September 2023.

How much disclosed funding has XVIVO raised?

As of Sep 13, 2023, XVIVO has disclosed funding of SEK1.3B (SEK). Undisclosed round amounts are excluded.

How many employees does XVIVO have?

XVIVO has 210 employees as of Sep 19, 2026.

Classification

Industry: Medical Devices
Ownership: Public
Technology: Machine Perfusion
Geographic Exposure: Global

Model: B2B
Revenue: Product Sales
Services Revenue
Customer: Hospitals

Tags: Organ Preservation
Organ Transplantation

Also Known As: XVIVO Group AB

Headquarters: Gemenskapens gata 9
Mölndal, Västra Götaland, 431 53
SE

Ticker: XVIVO
ISIN: SE0004840718